PDL Biopharma, Inc - Strategy, SWOT and Corporate Finance Report
Summary
PDL Biopharma, Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.
Key Highlights
PDL Biopharma, Inc., (PDL or 'the company') manages a portfolio of patents and royalty assets that include Queen et al. patents and license agreements with various pharmaceutical and biotechnology companies, and royalty and other acquired assets. It offers financing solutions and non-dilutive growth capital to public and private healthcare companies. PDL provides companies, academic institutions, and inventors with an immediate financial monetization of royalty streams for acquiring new income-generating assets. The company also carries out the humanization of monoclonal antibodies for facilitating the discovery of targeted treatments for cancer and other immunologic diseases. The company is headquartered in Reno, Nevada, the US
Scope
- Detailed information on PDL Biopharma, Inc required for business and competitor intelligence needs
- A study of the major internal and external factors affecting PDL Biopharma, Inc in the form of a SWOT analysis
- An in-depth view of the business model of PDL Biopharma, Inc including a breakdown and examination of key business segments
- Intelligence on PDL Biopharma, Inc's mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about PDL Biopharma, Inc, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends
- Gain understanding of PDL Biopharma, Inc and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess PDL Biopharma, Inc as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers' businesses better.
- Stay up to date on PDL Biopharma, Inc's business structure, strategy and prospects.
- Company Snapshot
- PDL Biopharma, Inc.: Company Overview
- PDL Biopharma, Inc.: Overview and Key Facts
- PDL Biopharma, Inc.: Overview
- PDL Biopharma, Inc.: Key Facts
- PDL Biopharma, Inc.: Key Employees
- PDL Biopharma, Inc.: Key Employee Biographies
- PDL Biopharma, Inc.: Major Products and Services
- PDL Biopharma, Inc.: Company History
- PDL Biopharma, Inc.: Management Statement
- PDL Biopharma, Inc.: Locations and Subsidiaries
- PDL Biopharma, Inc.: Key Competitors
- PDL Biopharma, Inc.: Company Analysis
- PDL Biopharma, Inc.: Business Description
- PDL Biopharma, Inc.: SWOT Analysis
- PDL Biopharma, Inc.: SWOT Overview
- PDL Biopharma, Inc.: Strengths
- PDL Biopharma, Inc.: Weaknesses
- PDL Biopharma, Inc.: Opportunities
- PDL Biopharma, Inc.: Threats
- PDL Biopharma, Inc.: Corporate Financial Deals Activity
- PDL Biopharma, Inc.: Financial Deals Overview
- PDL Biopharma, Inc.: Targets and Partners
- PDL Biopharma, Inc.: Top Deals 2018 - 2022YTD*
- PDL Biopharma, Inc.: Advisors
- PDL Biopharma, Inc.: Top Financial Advisors
- PDL Biopharma, Inc.: Mergers and Acquisitions
- PDL Biopharma, Inc.: Corporate Venturing
- PDL Biopharma, Inc.: Divestments
- PDL Biopharma, Inc.: Recent Developments
- PDL Biopharma, Inc.: News and Events Summary
- PDL Biopharma, Inc.: Business Expansion
- PDL Biopharma, Inc.: Contracts
- PDL Biopharma, Inc.: Corporate Governance
- PDL Biopharma, Inc.: Financial Deals
- PDL Biopharma, Inc.: Financial Performance
- PDL Biopharma, Inc.: Strategy and Operations
- Appendix
- Contact Us
- Methodology
- About MarketLine
- List of Tables
- Table 1: PDL Biopharma, Inc.: Key Facts
- Table 2: PDL Biopharma, Inc.: Key Employees
- Table 3: PDL Biopharma, Inc.: Company History
- Table 4: PDL Biopharma, Inc.: Locations and Subsidiaries
- Table 5: PDL Biopharma, Inc.: Key Competitors
- Table 6: PDL Biopharma, Inc.: Deal Activity by Deal Type - Volume (2018 - YTD*2022)
- Table 7: PDL Biopharma, Inc.: M&A Average Deal Size - Value (US$m)
- Table 8: PDL Biopharma, Inc.: Targets and Partners
- Table 9: PDL Biopharma, Inc.: Top Deals 2018 - 2022YTD*
- Table 10: PDL Biopharma, Inc.: Financial Advisor Ranking by Value (US$m)
- Table 11: PDL Biopharma, Inc.: M&A Volume and Value Trend (2018 - YTD*2022)
- Table 12: PDL Biopharma, Inc.: Corporate Venturing Volume and Value Trend (2018 - YTD*2022)
- Table 13: PDL Biopharma, Inc.: Corporate Venturing by Geography (2018 - YTD*2022)
- Table 14: PDL Biopharma, Inc.: Divestments Volume and Value Trend (2018 - YTD*2022)
- Table 15: PDL Biopharma, Inc.: Divestments by Geography (2018 - YTD*2022)
- Table 16: PDL Biopharma, Inc.: News and Events Summary
- Table 17: PDL Biopharma, Inc.: Business Expansion
- Table 18: PDL Biopharma, Inc.: Contracts
- Table 19: PDL Biopharma, Inc.: Corporate Governance
- Table 20: PDL Biopharma, Inc.: Financial Deals
- Table 21: PDL Biopharma, Inc.: Financial Performance
- Table 22: PDL Biopharma, Inc.: Strategy and Operations
- List of Figures
- Figure 1: PDL Biopharma, Inc.: Deal Activity by Deal Type - Volume (2018 - YTD*2022)
- Figure 2: PDL Biopharma, Inc.: M&A Average Deal Size - Value (US$m)
- Figure 3: PDL Biopharma, Inc.: M&A Volume and Value Trend (2018 - YTD*2022)
- Figure 4: PDL Biopharma, Inc.: Corporate Venturing Volume and Value Trend (2018 - YTD*2022)
- Figure 5: PDL Biopharma, Inc.: Corporate Venturing by Geography (2018 - YTD*2022)
- Figure 6: PDL Biopharma, Inc.: Divestments Volume and Value Trend (2018 - YTD*2022)
- Figure 7: PDL Biopharma, Inc.: Divestments by Geography (2018 - YTD*2022)
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook